We found that GBM patients with low SAA1 expression survived significantly longer than those with high expression if they were treated with TMZ at any time, and the patients who were treated with ionizing radiation (IR) alone, SAA1 expression had no significant effect on survival time (Fig. 5A). This evidence concerns the gene SAA1 and glioblastoma.